Zoonotic relevance of multidrug-resistant bacteria in parrots with respiratory illness
Ahmed Samir1, Tarek Mosallam2, Hassan Aboul-Ella1
1Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt.
Abstract:
Nowadays, research attention is paid to the investigation of bacterial pathogens in the cloaca of parrots rather than the nasal niche, which is largely ignored. Therefore, this study aimed to investigate the nasal carriage of multidrug-resistant bacteria with zoonotic potential in parrots suffering from respiratory illness. Nasal swabs were collected from 75 sick parrots with respiratory illness, and they were subjected to microbiological isolation and identification, followed by antimicrobial susceptibility testing. Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Staphylococcus aureus were isolated with a prevalence rate of 36%, 32%, 26.7%, and 9.3%, respectively, while one isolate (1.3%) of Staphylococcus pseudointermedius, Staphylococcus simulans, Staphylococcus sciuri, and Enterococcus faecalis was identified. E. coli, K. pneumoniae, and P. mirabilis were investigated for ESBL genes, Staphylococcus species for the mecA gene, followed by SCCmec typing, and E. faecalis for the vanA and vanB genes. Regarding beta-lactamase-encoding genes, blaTEM (97.6%), blaSHV (48.8%), and blaCTX-M (39%) gene families were detected, while blaOXA was not found. Sequencing of blaCTX-M in one strain of E. coli, K. pneumoniae, and P. mirabilis revealed blaCTX-M-15. The mecA was determined in three S. aureus and one S. sciuri strain, and the SCCmec typing of three MRSA isolates yielded type V, whereas type I in S. sciuri. Only the vanA gene was recognized in the E. faecalis strain. Moreover, 67.1% of bacterial isolates exhibited multidrug resistance. These findings highlight the potential role of parrots in the transmission of multidrug-resistant zoonotic bacteria, which may pose a threat to human contacts.
Insights
Parrots can carry multidrug-resistant bacteria like E. coli and S. aureus in their noses, posing a zoonotic risk. This study identified these resistant bacteria in sick parrots, highlighting potential transmission to humans.
Area of Science:
- Veterinary Microbiology
- Zoonotic Diseases
- Antimicrobial Resistance
Background:
- Research often overlooks the nasal niche of parrots for bacterial pathogens.
- Focus has shifted to cloacal investigations, leaving nasal carriage understudied.
- Parrots can harbor bacteria with zoonotic potential, posing a public health concern.
Purpose of the Study:
- To investigate nasal carriage of multidrug-resistant bacteria with zoonotic potential in parrots with respiratory illness.
- To identify specific bacterial species and their resistance genes.
- To assess the risk of parrots as reservoirs for zoonotic pathogens.
Main Methods:
- Nasal swabs collected from 75 sick parrots with respiratory symptoms.
- Microbiological isolation, identification, and antimicrobial susceptibility testing.
- Molecular investigation for specific resistance genes (ESBL, mecA, vanA/vanB) and SCCmec typing.
Main Results:
- Prevalence of Escherichia coli (36%), Klebsiella pneumoniae (32%), Proteus mirabilis (26.7%), and Staphylococcus aureus (9.3%) identified.
- Detection of beta-lactamase genes (blaTEM, blaSHV, blaCTX-M-15) and the mecA gene in resistant isolates.
- 67.1% of isolates showed multidrug resistance, with vanA gene found in Enterococcus faecalis.
Conclusions:
- Parrots with respiratory illness can be carriers of multidrug-resistant zoonotic bacteria.
- These findings indicate a potential role for parrots in transmitting resistant pathogens to humans.
- Further research is needed to understand the transmission dynamics and mitigate risks.
More Related Videos
08:46Rapid Diagnosis of Avian Influenza Virus in Wild Birds: Use of a Portable rRT-PCR and Freeze-dried Reagents in the Field
Published on: August 2, 2011
09:58Environmental Screening of Aeromonas hydrophila, Mycobacterium spp., and Pseudocapillaria tomentosa in Zebrafish Systems
Published on: December 8, 2017
Related Concept Videos
Viral Recombination
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Viral Mutations
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
